Literature DB >> 30131379

Paramacular temporal atrophy in sickle cell disease occurs early in childhood.

Gilles C Martin1,2, Eliane Albuisson3,4,5, Valentine Brousse6, Mariane de Montalembert6, Dominique Bremond-Gignac7, Matthieu P Robert7,2.   

Abstract

BACKGROUND/AIMS: Initially reported in a few patients with homozygous sickle cell disease (SCD), atrophic areas of the retina temporal from the macula are now known to be present in about 48% of eyes of adult patients with SS-SCD and in 35% of eyes of adult patients with SC-SCD. The aim of this study is to describe this paramacular atrophy in children affected with SCD.
METHODS: In this retrospective series, spectral-domain optical coherence tomography images of 81 children with SCD, acquired with specific patterns including one evaluating the retina temporal to the macula, were reviewed, in order to look for retinal atrophy. Fundus examination status for SCD peripheral retinopathy was also reviewed.
RESULTS: Mean age was 12.0 years (SD: 3.56). The genotype distribution was: 64 HbSS (79%), 10 HbSC (12%) and 7 HbS/β0 thalassaemia (9%). Using a usual fovea-centred programme, retinal atrophy was found in 38% of eyes (52% of children). Using a specific temporal pattern, retinal atrophy was found in 53% of eyes (64% of children), with no significant difference in the prevalence between HbSS and HbSC genotype (p=0.92), and no effect of age (mean 12.3 years (SD=3.61) vs11.9 (3.56), p=0.65). Peripheral retinopathy was found in 11% of children, with a significant relation between the HbSC genotype and the severity of the retinopathy (p=0.003).
CONCLUSION: Paramacular temporal atrophy occurs early in the course of SCD, which suggests distinct mechanisms from those of peripheral retinopathy. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  child health (paediatrics); macula; retina

Mesh:

Year:  2018        PMID: 30131379     DOI: 10.1136/bjophthalmol-2018-312305

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  SYSTEMIC MEDICATION USE AND THE INCIDENCE AND GROWTH OF GEOGRAPHIC ATROPHY IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS.

Authors:  Delu Song; Peiying Hua; Brian L VanderBeek; Joshua L Dunaief; Juan E Grunwald; Ebenezer Daniel; Maureen G Maguire; Daniel F Martin; Gui-Shuang Ying
Journal:  Retina       Date:  2021-07-01       Impact factor: 3.975

2.  Co-occurrence of sickle cell disease and oculocutaneous albinism in a Congolese patient: a case report.

Authors:  Benoît Mbiya Mukinayi; John Mpoyi Kalenda; Didier Kalombo Kalenda; Ghislain Disashi Tumba; Béatrice Gulbis
Journal:  J Med Case Rep       Date:  2021-12-19

3.  Retinal and choroidal thickness in pediatric patients with sickle cell disease: a cross-sectional cohort study.

Authors:  Juliana Prazeres; Luiz Filipe Lucatto; Adriano Ferreira; Nilva Moraes; Josefina A P Braga; Luiz H Lima; Caio Regatieri; Maurício Maia
Journal:  Int J Retina Vitreous       Date:  2022-03-04

Review 4.  [Maculopathy in sickle cell disease].

Authors:  Isabel Bachmeier; Christiane Blecha; Jürgen Föll; Daniel Wolff; Herbert Jägle
Journal:  Ophthalmologe       Date:  2021-01-27       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.